http://bkkcars.com/ru/car/43
Genzyme (NASDAQ: GENZ) found a virua strain and stopped production of two druga atthe Allston, Mass., facility. The strain, Vesivirus apparently does not cause human infectio but interrupts the growth of cells that are used to make Aldurazyme — a treatment for MPS I, a rare and fatak disease caused by an enzymew deficiency — was last filled at the Genzymr facility in September 2008, according to BioMarin (NASDAQ: BMRN). The company has about 10 months of vialedr inventoryon hand, it and uses a second fill finisu supplier. A third supplier is expected to be qualified later this BioMarin said.
BioMarin maked the bulk material used in Aldurazym e at its Novato The Food and Drug Administration hadinspectee Genzyme’s plant in September and October and reportedly was concernef about controls to protect against
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment